Endometriosis, a prevalent but debilitating condition affecting women, poses significant challenges in diagnosis and management. The current 2024 guideline, developed by the Korean Society of Endometriosis (KSE), builds upon the 2018 KSE guideline. This guideline aims to provide customized recommendations tailored to Korea’s unique clinical aspects and medical environment, and addresses key areas such as diagnosis, medical and surgical management, considerations for special populations, and its complex relationship with cancer.

Endometriosis, a prevalent but debilitating condition affecting women, poses significant challenges in diagnosis and management. The current 2024 guideline, developed by the Korean Society of Endometriosis (KSE), builds upon the 2018 KSE guideline. This guideline aims to provide customized recommendations tailored to Korea’s unique clinical aspects and medical environment, and addresses key areas such as diagnosis, medical and surgical management, considerations for special populations, and its complex relationship with cancer.

Endometriosis, a prevalent but debilitating condition affecting women, poses significant challenges in diagnosis and management. The current 2024 guideline, developed by the Korean Society of Endometriosis (KSE), builds upon the 2018 KSE guideline. This guideline aims to provide customized recommendations tailored to Korea’s unique clinical aspects and medical environment, and addresses key areas such as diagnosis, medical and surgical management, considerations for special populations, and its complex relationship with cancer.

Endometriosis, a prevalent but debilitating condition affecting women, poses significant challenges in diagnosis and management. The current 2024 guideline, developed by the Korean Society of Endometriosis (KSE), builds upon the 2018 KSE guideline. This guideline aims to provide customized recommendations tailored to Korea’s unique clinical aspects and medical environment, and addresses key areas such as diagnosis, medical and surgical management, considerations for special populations, and its complex relationship with cancer.

Endometriosis, a prevalent but debilitating condition affecting women, poses significant challenges in diagnosis and management. The current 2024 guideline, developed by the Korean Society of Endometriosis (KSE), builds upon the 2018 KSE guideline. This guideline aims to provide customized recommendations tailored to Korea’s unique clinical aspects and medical environment, and addresses key areas such as diagnosis, medical and surgical management, considerations for special populations, and its complex relationship with cancer.

Background: Human metapneumovirus (hMPV) is a major cause of acute respiratory infections in children and adults worldwide; however, no antiviral therapies or vaccines are currently available. Therefore, rapid and reliable diagnostic tools are required to support timely patient management and control outbreaks. Methods: We retrospectively evaluated GenBody hMPV Ag Rapid Test results using 165 consecutive clinical samples collected from patients with suspected respiratory infections between May and August 2024. Specimens were pre-characterized using a confirmatory reverse transcription-quantitative polymerase chain reaction (RT-qPCR) assay. Diagnostic performance was summarized using percent positive agreement (PPA), percent negative agreement (NPA), and overall percent agreement (OPA), with subgroup analyses by age and cycle threshold (Ct) groups. Results: The GenBody assay achieved a PPA of 92.7% (51/55), NPA of 100% (110/110), and OPA of 97.6% (161/165), with no false-positive results. Age-stratified analysis showed high PPA in infants (93.3%) and children (97%), whereas estimates in hMPV-positive adolescents (n = 2) and adults (n = 5) were less precise owing to the small sample size. In the Ct-stratified analysis, PPA was 100% for specimens with Ct < 28 (39/39), whereas all false-negative results occurred in the Ct > 28 group (12/16). Conclusion In this retrospective, single-center evaluation, the GenBody hMPV Ag Rapid Test showed high agreement with RT-qPCR, with reduced detection in specimens with higher Ct values. Further prospective studies and long-term stability assessments are warranted to confirm the performance across a broader range of clinical settings and storage conditions.